US Stock MarketDetailed Quotes

Aclaris Therapeutics (ACRS)

Watchlist
  • 4.250
  • +0.270+6.78%
Close Apr 17 16:00 ET
  • 4.250
  • 0.0000.00%
Post 20:01 ET
590.73MMarket Cap-8.02P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics (ACRS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-134.68%-47.11M
-46.91%-13.13M
-149.69%-10.93M
18.90%-9.99M
37.27%-13.06M
74.37%-20.08M
-32.20%-8.94M
189.59%22M
40.34%-12.32M
21.01%-20.82M
Net income from continuing operations
50.84%-64.92M
79.50%-19.8M
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
Depreciation and amortization
-43.74%454K
-28.67%102K
-38.55%110K
-52.89%114K
-47.33%128K
-6.49%807K
-37.28%143K
-18.26%179K
11.01%242K
22.73%243K
Deferred tax
----
----
----
----
----
--0
----
----
----
----
Other non cash items
-97.43%2.3M
-99.53%400K
-87.50%100K
650.00%1.5M
-89.29%300K
541.05%89.41M
535.18%85.61M
-52.94%800K
113.33%200K
450.00%2.8M
Change In working capital
-75.54%2.67M
425.55%3.24M
-97.61%612K
116.21%759K
78.51%-1.94M
16.33%10.92M
-107.49%-994K
909.45%25.6M
-227.37%-4.68M
-104.82%-9.01M
-Change in receivables
----
----
79.44%6.69M
16.67%56K
190.67%68K
-110.75%-20K
-7,847.92%-3.72M
4,283.53%3.73M
-81.18%48K
62.87%-75K
-Change in prepaid assets
225.91%6.14M
----
----
-531.14%-1.18M
301.57%8.21M
-270.72%-4.88M
-207.78%-8.6M
118.56%1.43M
137.35%273K
333.87%2.04M
-Change in payables and accrued expense
104.31%350K
-39.37%5.21M
322.05%1.67M
156.82%2.84M
14.55%-9.38M
-177.30%-8.13M
63.87%8.6M
-116.96%-753K
-220.50%-5M
-230.47%-10.98M
-Change in other working capital
-115.95%-3.82M
-28.04%-1.31M
---715K
---962K
---833K
--23.93M
---1.02M
----
----
----
Cash from discontinued investing activities
Operating cash flow
-134.68%-47.11M
-46.91%-13.13M
-149.69%-10.93M
18.90%-9.99M
37.27%-13.06M
74.37%-20.08M
-32.20%-8.94M
189.59%22M
40.34%-12.32M
21.01%-20.82M
Investing cash flow
Cash flow from continuing investing activities
169.32%48.37M
111.69%10.37M
394.81%13.83M
848.81%5.05M
13.58%19.12M
-250.95%-69.77M
-1,275.14%-88.72M
-91.41%2.8M
96.57%-674K
-34.75%16.83M
Net PPE purchase and sale
8.26%-111K
---24K
---23K
-250.00%-21K
68.15%-43K
90.76%-121K
--0
--0
106.06%14K
75.59%-135K
Net intangibles purchase and sale
--0
----
----
--0
---833K
---35.81M
----
----
--0
--0
Net business purchase and sale
---833K
--0
----
----
----
--0
--0
----
----
----
Net investment purchase and sale
245.72%49.31M
119.64%10.39M
395.64%13.85M
836.63%5.07M
17.84%20M
-171.19%-33.84M
-762.16%-52.91M
-91.43%2.8M
96.46%-688K
-35.61%16.97M
Cash from discontinued investing activities
Investing cash flow
169.32%48.37M
111.69%10.37M
394.81%13.83M
848.81%5.05M
13.58%19.12M
-250.95%-69.77M
-1,275.14%-88.72M
-91.41%2.8M
96.57%-674K
-34.75%16.83M
Financing cash flow
Cash flow from continuing financing activities
-107.86%-5.86M
-103.40%-2.53M
-13,936.36%-3.04M
18.18%-9K
-400.00%-275K
179.10%74.54M
152,104.08%74.58M
125.29%22K
-100.04%-11K
-55K
Net common stock issuance
--0
----
----
----
----
180.43%74.91M
--74.91M
--0
----
----
Proceeds from stock option exercised by employees
--0
--0
----
----
----
-65.96%32K
--0
113.33%32K
----
----
Net other financing activities
-1,333.25%-5.86M
-660.96%-2.53M
-30,340.00%-3.04M
18.18%-9K
-400.00%-275K
-300.98%-409K
---333K
---10K
---11K
---55K
Cash from discontinued financing activities
Financing cash flow
-107.86%-5.86M
-103.40%-2.53M
-13,936.36%-3.04M
18.18%-9K
-400.00%-275K
179.10%74.54M
152,104.08%74.58M
125.29%22K
-100.04%-11K
---55K
Net cash flow
Beginning cash position
-38.39%24.57M
-47.00%25.26M
11.25%25.4M
-15.30%30.36M
-38.39%24.57M
-11.92%39.88M
22.06%47.65M
-26.70%22.83M
-19.86%35.84M
-11.92%39.88M
Current changes in cash
69.89%-4.61M
77.05%-5.3M
-100.59%-146K
61.91%-4.96M
243.35%5.79M
-183.53%-15.31M
-2,854.30%-23.08M
214.54%24.82M
4.16%-13.01M
-627.39%-4.04M
End cash Position
-18.76%19.96M
-18.76%19.96M
-47.00%25.26M
11.25%25.4M
-15.30%30.36M
-38.39%24.57M
-38.39%24.57M
22.06%47.65M
-26.70%22.83M
-19.86%35.84M
Free cash flow
15.68%-47.22M
70.60%-13.16M
-146.01%-10.12M
18.64%-10.01M
33.49%-13.93M
29.67%-56.01M
-521.33%-44.75M
189.28%22M
41.07%-12.31M
22.14%-20.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -134.68%-47.11M-46.91%-13.13M-149.69%-10.93M18.90%-9.99M37.27%-13.06M74.37%-20.08M-32.20%-8.94M189.59%22M40.34%-12.32M21.01%-20.82M
Net income from continuing operations 50.84%-64.92M79.50%-19.8M-92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M
Depreciation and amortization -43.74%454K-28.67%102K-38.55%110K-52.89%114K-47.33%128K-6.49%807K-37.28%143K-18.26%179K11.01%242K22.73%243K
Deferred tax ----------------------0----------------
Other non cash items -97.43%2.3M-99.53%400K-87.50%100K650.00%1.5M-89.29%300K541.05%89.41M535.18%85.61M-52.94%800K113.33%200K450.00%2.8M
Change In working capital -75.54%2.67M425.55%3.24M-97.61%612K116.21%759K78.51%-1.94M16.33%10.92M-107.49%-994K909.45%25.6M-227.37%-4.68M-104.82%-9.01M
-Change in receivables --------79.44%6.69M16.67%56K190.67%68K-110.75%-20K-7,847.92%-3.72M4,283.53%3.73M-81.18%48K62.87%-75K
-Change in prepaid assets 225.91%6.14M---------531.14%-1.18M301.57%8.21M-270.72%-4.88M-207.78%-8.6M118.56%1.43M137.35%273K333.87%2.04M
-Change in payables and accrued expense 104.31%350K-39.37%5.21M322.05%1.67M156.82%2.84M14.55%-9.38M-177.30%-8.13M63.87%8.6M-116.96%-753K-220.50%-5M-230.47%-10.98M
-Change in other working capital -115.95%-3.82M-28.04%-1.31M---715K---962K---833K--23.93M---1.02M------------
Cash from discontinued investing activities
Operating cash flow -134.68%-47.11M-46.91%-13.13M-149.69%-10.93M18.90%-9.99M37.27%-13.06M74.37%-20.08M-32.20%-8.94M189.59%22M40.34%-12.32M21.01%-20.82M
Investing cash flow
Cash flow from continuing investing activities 169.32%48.37M111.69%10.37M394.81%13.83M848.81%5.05M13.58%19.12M-250.95%-69.77M-1,275.14%-88.72M-91.41%2.8M96.57%-674K-34.75%16.83M
Net PPE purchase and sale 8.26%-111K---24K---23K-250.00%-21K68.15%-43K90.76%-121K--0--0106.06%14K75.59%-135K
Net intangibles purchase and sale --0----------0---833K---35.81M----------0--0
Net business purchase and sale ---833K--0--------------0--0------------
Net investment purchase and sale 245.72%49.31M119.64%10.39M395.64%13.85M836.63%5.07M17.84%20M-171.19%-33.84M-762.16%-52.91M-91.43%2.8M96.46%-688K-35.61%16.97M
Cash from discontinued investing activities
Investing cash flow 169.32%48.37M111.69%10.37M394.81%13.83M848.81%5.05M13.58%19.12M-250.95%-69.77M-1,275.14%-88.72M-91.41%2.8M96.57%-674K-34.75%16.83M
Financing cash flow
Cash flow from continuing financing activities -107.86%-5.86M-103.40%-2.53M-13,936.36%-3.04M18.18%-9K-400.00%-275K179.10%74.54M152,104.08%74.58M125.29%22K-100.04%-11K-55K
Net common stock issuance --0----------------180.43%74.91M--74.91M--0--------
Proceeds from stock option exercised by employees --0--0-------------65.96%32K--0113.33%32K--------
Net other financing activities -1,333.25%-5.86M-660.96%-2.53M-30,340.00%-3.04M18.18%-9K-400.00%-275K-300.98%-409K---333K---10K---11K---55K
Cash from discontinued financing activities
Financing cash flow -107.86%-5.86M-103.40%-2.53M-13,936.36%-3.04M18.18%-9K-400.00%-275K179.10%74.54M152,104.08%74.58M125.29%22K-100.04%-11K---55K
Net cash flow
Beginning cash position -38.39%24.57M-47.00%25.26M11.25%25.4M-15.30%30.36M-38.39%24.57M-11.92%39.88M22.06%47.65M-26.70%22.83M-19.86%35.84M-11.92%39.88M
Current changes in cash 69.89%-4.61M77.05%-5.3M-100.59%-146K61.91%-4.96M243.35%5.79M-183.53%-15.31M-2,854.30%-23.08M214.54%24.82M4.16%-13.01M-627.39%-4.04M
End cash Position -18.76%19.96M-18.76%19.96M-47.00%25.26M11.25%25.4M-15.30%30.36M-38.39%24.57M-38.39%24.57M22.06%47.65M-26.70%22.83M-19.86%35.84M
Free cash flow 15.68%-47.22M70.60%-13.16M-146.01%-10.12M18.64%-10.01M33.49%-13.93M29.67%-56.01M-521.33%-44.75M189.28%22M41.07%-12.31M22.14%-20.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -